FindMyKOL

Scott Kuwada, MD

Basic profile

University of Hawaiʻi at Mānoa

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionHonolulu, HI · WestSpecialtyGastroenterologyFocusGastroenterology
Active KOLFindMyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Scott Kuwada is a Gastroenterology physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 122 publications with 3,629 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
122publications

Publications indexed by OpenAlex. Counts exclude supporting files.

3,629citations

Citations across these publications.

28h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Janssen Scientific Affairs, LLC
    Program year20251 payment
    $85
  • ABBVIE INC.
    Program year20253 payments
    $73
  • Terumo Medical Corporation
    Program year20241 payment
    $131
All 19 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    73.3%
    Proton pump inhibitor27%
    Omeprazole74%Pantoprazole Sodium26%
    Part D<11 patients
    Aluminum Complex13%
    Sucralfate100%
    Part D<11 patients

    + 3 more classes in this area

  • Cancer & immunology

    15.6%
    Interleukin-12 Antagonist8.6%
    Stelara100%
    Part D<11 patients
    TNF inhibitor7%
    Humira(Cf) Pen100%
    Part D<11 patients
  • Blood & clotting

    6%
    Solutions for parenteral nutrition6%
    Peg 3350-Electrolyte100%
    Part D≥17 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”